Saturday, February 19, 2022

Covaxin to Be Evaluated as Covid-19 Vaccine Candidate in US as USFDA Lifts Clinical Hold

Overall, Covaxin has more than 15 publications elucidating all aspects of the safety, immunogenicity, efficacy and effectiveness, in adults and ch

from Top Business News- News18.com
via IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)